Taro Pharmaceutical Industries Ltd. (TARO) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Taro Pharmaceutical Industries Ltd., with annual and quarterly history.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 29.47x | 35.92x | 27.95x | -7.03x | 9.64x | 15.07x |
| P/B Ratio | 0.89x | 0.53x | 0.95x | 1.65x | 1.12x | 2.23x |
| P/S Ratio | 2.52x | 1.60x | 2.90x | 5.13x | 3.65x | 6.34x |
| Profitability | ||||||
| Gross Margin | 48.5% | 46.8% | 52.2% | 54.0% | 62.0% | 66.5% |
| Operating Margin | 3.4% | 3.1% | 32.8% | 128.3% | 38.2% | 44.2% |
| Net Margin | 8.6% | 4.4% | 10.4% | -73.0% | 37.9% | 42.1% |
| EBITDA Margin | 6.1% | 9.7% | 29.4% | -75.4% | 47.4% | 56.1% |
| Liquidity | ||||||
| Current Ratio | 3.61x | 3.47x | 3.10x | 2.17x | 6.88x | 6.84x |
| Quick Ratio | 3.04x | 2.88x | 2.61x | 1.91x | 6.19x | 6.16x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..